The website www.sympany.ch cannot be displayed correctly. Please update your browser: https://browsehappy.com
The strategic realignment is bearing fruit – Sympany reports a profit of CHF 22.5 million for the 2024 financial year. With equity of CHF 395 million and a solvency ratio well above the legal minimum, the company’s foundations remain very sound. Sympany records above-average customer growth as of 2025. Read more
This year’s Sympany Foundation Day focused on the Sawera Health Foundation – a digital health initiative that helps children and their families to manage their everyday lives around childhood cancer treatments. Read more
Healthcare costs continued to rise in Switzerland in 2023, which also had an impact on Sympany’s business. The company closed 2023 with a loss of CHF 58.2 million since the tightly calculated premiums were unable to cushion the high inflation. As the high equity base shows, Sympany remains in a good financial position. It was able to maintain strong customer growth in 2023 and once again achieve excellent satisfaction scores in independent customer surveys. Read more
This contact is intended exclusively for journalists. Our Customer Service (tel. +41 58 262 42 00) will provide you with all other information including marketing enquiries.
For all other requests please contact Customer Services